VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS30078583 | HIV | ENSG00000113749.8 | protein_coding | HRH2 | No | No | 3274 | A0A1B0GTK7 P25021 |
TVIS20009148 | HPV | ENSG00000113749.8 | protein_coding | HRH2 | No | No | 3274 | A0A1B0GTK7 P25021 |
TVIS20009386 | HPV | ENSG00000113749.8 | protein_coding | HRH2 | No | No | 3274 | A0A1B0GTK7 P25021 |
TVIS20059821 | HPV | ENSG00000113749.8 | protein_coding | HRH2 | No | No | 3274 | A0A1B0GTK7 P25021 |
TVIS44038999 | HTLV-1 | ENSG00000113749.8 | protein_coding | HRH2 | No | No | 3274 | A0A1B0GTK7 P25021 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | HRH2 |
---|---|
DrugBank ID | DB08806 |
Drug Name | Roxatidine acetate |
Target ID | BE0000112 |
UniProt ID | P25021 |
Regulation Type | antagonist |
PubMed IDs | 20718616 |
Citations | Agrawal SS, Alvin Jose M: Roxatidine, an H(2) receptor blocker, is an estrogenic compound--experimental evidence. Syst Biol Reprod Med. 2010 Aug;56(4):286-91. doi: 10.3109/19396368.2010.496894. |
Groups | Experimental |
Direct Classification | N-benzylpiperidines |
SMILES | CC(=O)OCC(=O)NCCCOC1=CC=CC(CN2CCCCC2)=C1 |
Pathways | Roxatidine Acetate Action Pathway |
PharmGKB | PA165958424 |
ChEMBL | CHEMBL46102 |